EO2 (ALEO2.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:ALEO2 • FR0010465534

2.42 EUR
-0.08 (-3.2%)
Last: Feb 10, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

ALEO2 gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 74 industry peers in the Oil, Gas & Consumable Fuels industry. ALEO2 scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALEO2 does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • ALEO2 had negative earnings in the past year.
  • ALEO2 had a positive operating cash flow in the past year.
  • Of the past 5 years ALEO2 4 years were profitable.
  • ALEO2 had a positive operating cash flow in 4 of the past 5 years.
ALEO2.PA Yearly Net Income VS EBIT VS OCF VS FCFALEO2.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M -4M 6M -6M

1.2 Ratios

  • ALEO2 has a Return On Assets of -0.23%. This is in the lower half of the industry: ALEO2 underperforms 75.68% of its industry peers.
  • The Return On Equity of ALEO2 (-0.45%) is worse than 75.68% of its industry peers.
Industry RankSector Rank
ROA -0.22%
ROE -0.45%
ROIC N/A
ROA(3y)3.7%
ROA(5y)2.69%
ROE(3y)8.38%
ROE(5y)6.12%
ROIC(3y)N/A
ROIC(5y)N/A
ALEO2.PA Yearly ROA, ROE, ROICALEO2.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

1.3 Margins

  • Looking at the Gross Margin, with a value of 55.94%, ALEO2 is in the better half of the industry, outperforming 64.86% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ALEO2 has grown nicely.
  • ALEO2 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.8%
GM growth 5Y19.22%
ALEO2.PA Yearly Profit, Operating, Gross MarginsALEO2.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • ALEO2 does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ALEO2 has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ALEO2 has been reduced compared to 5 years ago.
  • ALEO2 has a better debt/assets ratio than last year.
ALEO2.PA Yearly Shares OutstandingALEO2.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M 2.5M
ALEO2.PA Yearly Total Debt VS Total AssetsALEO2.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

  • Based on the Altman-Z score of 1.54, we must say that ALEO2 is in the distress zone and has some risk of bankruptcy.
  • ALEO2 has a Altman-Z score (1.54) which is comparable to the rest of the industry.
  • ALEO2 has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of ALEO2 (0.36) is better than 67.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 1.54
ROIC/WACCN/A
WACC5.88%
ALEO2.PA Yearly LT Debt VS Equity VS FCFALEO2.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M 15M 20M

2.3 Liquidity

  • A Current Ratio of 2.14 indicates that ALEO2 has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 2.14, ALEO2 belongs to the best of the industry, outperforming 83.78% of the companies in the same industry.
  • ALEO2 has a Quick Ratio of 1.46. This is a normal value and indicates that ALEO2 is financially healthy and should not expect problems in meeting its short term obligations.
  • ALEO2's Quick ratio of 1.46 is fine compared to the rest of the industry. ALEO2 outperforms 77.03% of its industry peers.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 1.46
ALEO2.PA Yearly Current Assets VS Current LiabilitesALEO2.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • ALEO2 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -642.86%.
  • ALEO2 shows a decrease in Revenue. In the last year, the revenue decreased by -0.28%.
  • ALEO2 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.28% yearly.
EPS 1Y (TTM)-642.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-187.5%
Revenue 1Y (TTM)-0.28%
Revenue growth 3Y-0.53%
Revenue growth 5Y4.28%
Sales Q2Q%1.5%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALEO2.PA Yearly Revenue VS EstimatesALEO2.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALEO2. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALEO2.PA Price Earnings VS Forward Price EarningsALEO2.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALEO2 is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.64
ALEO2.PA Per share dataALEO2.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ALEO2!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EO2

EPA:ALEO2 (2/10/2026, 7:00:00 PM)

2.42

-0.08 (-3.2%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners28.33%
Ins Owner ChangeN/A
Market Cap5.81M
Revenue(TTM)30.41M
Net Income(TTM)-90.00K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.19
P/FCF N/A
P/OCF 3.14
P/B 0.28
P/tB 0.3
EV/EBITDA 6.64
EPS(TTM)-0.38
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)0.77
OCFY31.85%
SpS12.57
BVpS8.75
TBVpS8.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.22%
ROE -0.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.94%
FCFM N/A
ROA(3y)3.7%
ROA(5y)2.69%
ROE(3y)8.38%
ROE(5y)6.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.8%
GM growth 5Y19.22%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA 3.68
Cap/Depr 79.14%
Cap/Sales 9.19%
Interest Coverage N/A
Cash Conversion 93.43%
Profit Quality N/A
Current Ratio 2.14
Quick Ratio 1.46
Altman-Z 1.54
F-Score5
WACC5.88%
ROIC/WACCN/A
Cap/Depr(3y)115.4%
Cap/Depr(5y)96.64%
Cap/Sales(3y)8.27%
Cap/Sales(5y)6.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-642.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-187.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.28%
Revenue growth 3Y-0.53%
Revenue growth 5Y4.28%
Sales Q2Q%1.5%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-480%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y86.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y169.92%
OCF growth 3Y-29.17%
OCF growth 5Y-11.33%

EO2 / ALEO2.PA FAQ

What is the ChartMill fundamental rating of EO2 (ALEO2.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALEO2.PA.


Can you provide the valuation status for EO2?

ChartMill assigns a valuation rating of 0 / 10 to EO2 (ALEO2.PA). This can be considered as Overvalued.


Can you provide the profitability details for EO2?

EO2 (ALEO2.PA) has a profitability rating of 2 / 10.


What is the financial health of EO2 (ALEO2.PA) stock?

The financial health rating of EO2 (ALEO2.PA) is 5 / 10.